Centre Hospitalier de Valenciennes-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2020

  1. Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

    British Journal of Haematology, Vol. 189, Núm. 1, pp. 84-96